Alpha 2.0
Login Register
» Articles » PMID: 316725

Treatment of Acute Lymphoblastic Leukemia with 2'-deoxycoformycin: Clinical and Biochemical Consequences of Adenosine Deaminase Inhibition

Overview
Journal Cancer Treat Rep
Specialty Oncology
Date 1979 Nov 1
PMID 316725
Citations 10
Authors
C A Koller
B S Mitchell
M R Grever
E Mejias
L Malspeis
E N METZ
Affiliations
Soon will be listed here.
Citing Articles

Evolution of the arabinosides and the pharmacology of fludarabine.

Plunkett W, Gandhi V Drugs. 1994; 47 Suppl 6:30-8.

PMID: 7525187 DOI: 10.2165/00003495-199400476-00006.

Adenosine deaminase inhibitors: their role in chemotherapy and immunosuppression.

Glazer R Cancer Chemother Pharmacol. 1980; 4(4):227-35.

PMID: 7002342 DOI: 10.1007/BF00255266.

Adenosine and deoxyadenosine toxicity in colony assay systems for human T-lymphocytes, B-lymphocytes, and granulocytes.

Brox L, Pollock E, Belch A Cancer Chemother Pharmacol. 1982; 9(1):49-52.

PMID: 6982786 DOI: 10.1007/BF00296762.

Purinogenic lymphocytotoxicity: clues to a wider chemotherapeutic potential for the adenosine deaminase inhibitors.

Kefford R, Fox R Cancer Chemother Pharmacol. 1983; 10(2):73-8.

PMID: 6600985 DOI: 10.1007/BF00446213.

Antileukemic and immunosuppressive activity of 2-chloro-2'-deoxyadenosine.

Carson D, Wasson D, Beutler E Proc Natl Acad Sci U S A. 1984; 81(7):2232-6.

PMID: 6585795 PMC: 345472. DOI: 10.1073/pnas.81.7.2232.